The Patent Finder

Formulations of Bendamustine (2011)

Eagle Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 11 of these applications claim priority to application 61/299,100, filed Jan 28, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,609,707Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,265,831Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,572,796Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,572,797Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 10,010,533Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 11,103,483Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, IncIn force
High confidence
US 11,844,783Formulations of Bendamustine
In force
 · Medium confidence
Eagle Pharmaceuticals, Inc.In force
Medium confidence
US 11,872,214Formulations of Bendamustine
In force
 · Medium confidence
Eagle Pharmaceuticals, Inc.In force
Medium confidence
US 12,138,248Formulations of Bendamustine
In force
 · Medium confidence
Eagle Pharmaceuticals, Inc.In force
Medium confidence
US 12,343,333Formulations of Bendamustine
In force
 · Medium confidence
Eagle Pharmaceuticals, Inc.In force
Medium confidence
8 more patents in this group · Pro
10 of 18 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 18.
Upgrade to Pro
11 of these are in force and held by Eagle Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited